Literature DB >> 23800537

Prevalence and predictors of persistent versus remitting mood, anxiety, and substance disorders in a national sample of older adults.

Corey S Mackenzie1, Renée El-Gabalawy1, Kee-Lee Chou2, Jitender Sareen3.   

Abstract

OBJECTIVES: Relatively little is known about whether mental disorders other than depression remit versus persist in later life, especially within nationally representative samples. Our objectives were to examine the prevalence of persistent mood, anxiety, and substance disorders in older adults and to explore a range of physical and mental health predictors of disorder chronicity.
METHODS: This study involved a 3-year follow-up design using Wave 1 (2001-2002) and Wave 2 (2004-2005) of the National Epidemiologic Survey on Alcohol and Related Conditions. Participants included 1,994 adults aged 55 years and older who had a past-year mental disorder at Wave 1 and who completed Wave 2. The primary outcome was the prevalence of persistent mood, anxiety, and substance disorders at Wave 2. Potential predictors of persistence included sociodemographic variables, physical health (chronic health conditions and physical health-related quality of life), and mental health (childhood adversity, suicide attempts, mental health-related quality of life, comorbid mental disorders, personality disorders, and lifetime treatment-seeking).
RESULTS: With the exception of nicotine dependence, the prevalence of persistent mood, anxiety, and substance disorders ranged from 13% to 33%. Only younger age predicted substance disorder chronicity. Significant predictors of persistent mood and anxiety disorders included physical and mental health comorbidity, physical health- and mental health-related quality of life, suicide attempts, comorbid personality disorders, and treatment-seeking.
CONCLUSIONS: At least two-thirds of mental disorders in these older adults were not persistent. Sociodemographic variables had little influence on chronicity, whereas a number of markers of mental disorder severity and complexity predicted persistent mood and anxiety disorders. The findings have important treatment and prevention implications.
Copyright © 2014 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; longitudinal; mental disorders; persistence; remission

Mesh:

Year:  2013        PMID: 23800537      PMCID: PMC4284958          DOI: 10.1016/j.jagp.2013.02.007

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  38 in total

1.  Epidemiology of social phobia in later life.

Authors:  John Cairney; Laura McCabe; Scott Veldhuizen; Laurie M Corna; David Streiner; Nathan Herrmann
Journal:  Am J Geriatr Psychiatry       Date:  2007-01-09       Impact factor: 4.105

2.  Onset and persistence of depression in older people--results from a 2-year community follow-up study.

Authors:  Tess Harris; Derek G Cook; Christina Victor; Stephen DeWilde; Carole Beighton
Journal:  Age Ageing       Date:  2005-11-22       Impact factor: 10.668

3.  Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication.

Authors:  Philip S Wang; Michael Lane; Mark Olfson; Harold A Pincus; Kenneth B Wells; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 4.  The prognosis of depression in older patients in general practice and the community. A systematic review.

Authors:  Els Licht-Strunk; Daniëlle A W M van der Windt; Harm W J van Marwijk; Marten de Haan; Aartjan T F Beekman
Journal:  Fam Pract       Date:  2007-01-20       Impact factor: 2.267

5.  Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD).

Authors:  Jordi Alonso; Jean-Pierre Lépine
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

6.  An epidemiological approach to depression prevention in old age.

Authors:  Filip Smits; Niels Smits; Robert Schoevers; Dorly Deeg; Aartjan Beekman; Pim Cuijpers
Journal:  Am J Geriatr Psychiatry       Date:  2008-06       Impact factor: 4.105

7.  Factors associated with persistent risk of depression in older people following discharge from an acute cardiac unit.

Authors:  A J Hammond; S Yu; K Esa; J Jabbour; L Wakefield; P Ryan; R Visvanathan
Journal:  Int Psychogeriatr       Date:  2008-04-09       Impact factor: 3.878

8.  Higher burden of depression among older women: the effect of onset, persistence, and mortality over time.

Authors:  Lisa C Barry; Heather G Allore; Zhenchao Guo; Martha L Bruce; Thomas M Gill
Journal:  Arch Gen Psychiatry       Date:  2008-02

9.  Prevalence of mental disorders in the elderly: the Australian National Mental Health and Well-Being Survey.

Authors:  Julian N Trollor; Tracy M Anderson; Perminder S Sachdev; Henry Brodaty; Gavin Andrews
Journal:  Am J Geriatr Psychiatry       Date:  2007-06       Impact factor: 4.105

10.  Persistent depression and anxiety in the United States: prevalence and quality of care.

Authors:  Alexander S Young; Ruth Klap; Rebecca Shoai; Kenneth B Wells
Journal:  Psychiatr Serv       Date:  2008-12       Impact factor: 4.157

View more
  9 in total

1.  Race-related differences in depression onset and recovery in older persons over time: the health, aging, and body composition study.

Authors:  Lisa C Barry; Roland J Thorpe; Brenda W J H Penninx; Kristine Yaffe; Dorothy Wakefield; Hilsa N Ayonayon; Suzanne Satterfield; Anne B Newman; Eleanor M Simonsick
Journal:  Am J Geriatr Psychiatry       Date:  2013-10-11       Impact factor: 4.105

Review 2.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 3.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

Review 4.  The natural history of substance use disorders.

Authors:  Aaron L Sarvet; Deborah Hasin
Journal:  Curr Opin Psychiatry       Date:  2016-07       Impact factor: 4.741

5.  The Emerging Empirical Science of Wisdom: Definition, Measurement, Neurobiology, Longevity, and Interventions.

Authors:  Dilip V Jeste; Ellen E Lee
Journal:  Harv Rev Psychiatry       Date:  2019 May/Jun       Impact factor: 3.732

6.  Psychopathology and HIV diagnosis among older adults in the United States: disparities by age, sex, and race/ethnicity.

Authors:  Monique J Brown; Steven A Cohen; Jonathan P DeShazo
Journal:  Aging Ment Health       Date:  2019-07-05       Impact factor: 3.658

Review 7.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-26       Impact factor: 4.328

8.  Relative Association of Multi-Level Supportive Environments on Poor Health among Older Adults.

Authors:  Nelda Mier; Marcia G Ory; Samuel D Towne; Matthew Lee Smith
Journal:  Int J Environ Res Public Health       Date:  2017-04-06       Impact factor: 3.390

9.  Lifetime Prevalence and Comorbidity of Mental Disorders in the Two-wave 2002-2018 Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey (CAFVMHS): Prévalence et Comorbidité de Durée de vie Des Troubles Mentaux Dans l'Enquête de Suivi Sur la Santé Mentale Auprès des Membres des Forces Armées Canadiennes et Des ex-Militaires (ESSMFACM) en Deux Cycles de 2002 à 2018.

Authors:  Jitender Sareen; Shay-Lee Bolton; Natalie Mota; Tracie O Afifi; Murray W Enns; Tamara Taillieu; Ashley Stewart-Tufescu; Renée El-Gabalawy; Ruth Ann Marrie; J Don Richardson; Murray B Stein; Charles N Bernstein; James M Bolton; Jianli Wang; Gordon J G Asmundson; James M Thompson; Linda VanTil; Mary Beth MacLean; Sarvesh Logsetty
Journal:  Can J Psychiatry       Date:  2021-03-15       Impact factor: 4.356

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.